Why Sun Pharma Advanced Share Price is Rising

Over the past month, the pharma sector has outperformed the benchmark indices. While the Nifty 50 has inched up 0.7%, the Nifty Pharma index has rallied more than 1.7%, extending the sector's strong momentum that began in early October 2025.

Just yesterday, we covered the sharp spike in Why Wockhardt Share Price is Rising.

And today, another pharma name has stolen the spotlight, Sun Pharma Advanced.

The stock jumped more than 11% to Rs 179.5 on the BSE on Wednesday, marking a second consecutive day of gains following a 20% jump in the previous session.

Here's what's fuelling this sudden surge.

# Favourable Ruling for Sezaby PRV

Sun Pharma Advanced Research Company (SPARC) saw its shares rally after receiving a favourable US court ruling related to the Priority Review Voucher (PRV) for its drug Sezaby.

On 2 December 2025, the US District Court for the District of Columbia ruled in SPARC's favour in its case against the USFDA. The dispute began when the FDA refused to issue a PRV for Sezaby, which SPARC challenged.

The court stated that the FDA's refusal was "contrary to law," and clarified that no earlier phenobarbital sodium drug had been approved under the criteria that determine PRV eligibility. This directly supported SPARC's argument.

With this judgment, SPARC now has a stronger claim to the PRV, a valuable asset that can speed up the approval process for future drugs. The FDA, however, has 60 days to appeal the decision.

Sezaby is a benzyl alcohol-free, propylene glycol-free phenobarbital sodium injectable powder. It is approved in the U.S. for treating seizures in newborn babies.

What Next?

Going forward, the company plans to strengthen its long-term R&D capabilities through a major consolidation strategy.

As part of this roadmap, it will merge its research infrastructure and laboratory operations - currently spread across multiple locations in Mumbai and Baroda - into two key R&D hubs based in Baroda.

This strategic move is designed to speed up the proof-of-concept stage for pipeline assets by streamlining workflows, improving coordination, and reducing development cycle times. The ongoing R&D activities at the Mahakali facility in Mumbai and the Makarpura unit in Baroda will be gradually integrated into the company's Savli and Tandalja campuses, which will serve as its primary innovation centres.

To further optimise costs and drive flexibility, the company will also outsource select R&D functions to specialised third-party partners whenever required.

With laboratory operations being consolidated and certain tasks being outsourced, the company expects some excess capacity in internal functions. It plans to rationalise and streamline these areas by the end of FY26.

How shares of Sun Pharma Advanced Research have performed recently

Shares of Sun Pharma Advanced Research Company (SPARC) jumped 11% to Rs 179.5 on the BSE on Wednesday, extending their rally after a sharp 20% surge in the previous session.

In past one month the shares of the company rallied over 16%.

The stock touched its 52-week high of Rs 240.95 on 16 December 2024 and its 52-week low of Rs 109.2 on 3 March 2025.

About Sun Pharma Advanced Research Company (SPARC)

Sun Pharma Advanced Research Company is a research-driven specialty pharmaceutical company dedicated to creating next-generation medicines.

Originally formed as a spin-off from Sun Pharma, the company now operates independently with a strong focus on innovation and advanced drug development.

SPARC works on three major areas: improved drug delivery systems, novel formulations of existing medicines, and entirely new chemical entities.

Its research spans key therapeutic segments such as oncology, neurology, ophthalmology, and dermatology.

The company's goal is to develop differentiated, high-value therapies that address unmet medical needs and bring these solutions to global markets.

For more details, see the SUN PHARMA ADV. RES. company fact sheet and quarterly results.

Happy Investing!

Investors should evaluate the company's fundamentals, corporate governance, and valuations of the stock as key factors when conducting due diligence before making investment decisions.

To know what's moving the Indian stock markets today, check out the most recent share market updates here.

Happy Investing.

Disclaimer: This article is for information purposes only. It is not a stock recommendation and should not be treated as such. Learn more about our recommendation services here...